Intervention for Depression

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
New York State Psychiatric Institute, New York, NY
Depression+2 More
Mindfulness-based Intervention (Headspace TM) - Behavioral
Eligibility
Any Age
All Sexes
What conditions do you have?
Select

Study Summary

The current study is the second phase of a two-part study to examine the feasibility and utility of using an mHealth mindfulness intervention to help parents mitigate the stress associated with the impact of sustained community crisis situations, such as COVID-19 and its consequences, on low-income families living in under-resourced settings.

Eligible Conditions

  • Depression
  • Anxiety
  • Stress, Psychological

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: Baseline, Posttreatment (6 weeks), Follow up (10-14 weeks)

Week 14
Change in Generalized Anxiety Disorder-7 (GAD-7)
Change in Patient Health Questionnaire-9 (PHQ-9)
Change in Perceived Stress Scale (PSS-10)

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Waitlist Control
1 of 2
Intervention
1 of 2
Active Control
Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: Intervention · No Placebo Group · N/A

Intervention
Behavioral
Experimental Group · 1 Intervention: Mindfulness-based Intervention (Headspace TM) · Intervention Types: Behavioral
Waitlist ControlNoIntervention Group · 1 Intervention: Waitlist Control · Intervention Types:

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: baseline, posttreatment (6 weeks), follow up (10-14 weeks)

Trial Background

Prof. Cristiane Duarte, Ruane Professor for the Implementation of Science for Child and Adolescent mental Health (in Psychiatry) at CUMC
Principal Investigator
New York State Psychiatric Institute
Closest Location: New York State Psychiatric Institute · New York, NY
Photo of New York  1Photo of New York  2Photo of New York  3
2001First Recorded Clinical Trial
51 TrialsResearching Depression
212 CompletedClinical Trials

Eligibility Criteria

Age Any Age · All Participants · 3 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You have access to a smartphone, tablet, or computer with at least periodic internet access.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.